
Manhattan, NY- May 19, 2014 – ( Techsonian ) –Volkswagen AG (ADR) ( OTCMKTS:VLKPY )together with its subsidiaries, manufactures and sells automobiles primarily in Europe, North America, South America, and the Asia-Pacific. The company operates through four segments: Passenger Cars, Commercial Vehicles, Power Engineering, and Financial Services.

Volkswagen AG (ADR) ( OTCMKTS:VLKPY ) gained volume of 33,515 shares and the average volume of the stock remained 12,705 shares. The 52 week range of the stock remained $38.38 – $56.73.The stock opened the session at $51.46, and closed the session at $51.77. The stock showed a positive performance of 0.11% in previous trading session.

ICAP plc (ADR) ( OTCMKTS:IAPLY ),acts as markets operator and provides post trade risk mitigation and information services. It offers electronic execution, risk mitigation, messaging, broking, and information services for wholesale market participants. The company works in three segments: Global Broking, Electronic Markets, and Post Trade Risk and Information.

In previous session, ICAP plc (ADR) ( OTCMKTS:IAPLY ) traded 44,373 shares and the average volume of the stock remained 44,447 shares. The 52 week range of the stock remained $10.28 – $15.49. The stock was a bull and advanced 1.56%, while its closing price stayed at $13.05.

Koninklijke KPN N.V. (ADR) ( OTCMKTS:KKPNY ) provides telecommunications, and information and communication technology services. It offers fixed and mobile telephony, broadband Internet, and television service, as well as mobile access portfolio of voice, SMS, and data services offering postpaid and prepaid products to consumers. The company also provides voice and broadband services, such as fixed-mobile communication solutions; and network communication services ranging from traditional data services to virtual private network services, such as IP-VPN and E-VPN for business customers.

Koninklijke KPN N.V. (ADR) ( OTCMKTS:KKPNY ) volume of the stock was 3.03 million shares in the most recent session and the average volume remained 148,642 shares. The stock added 1.10% and finished the prior session at the closing price of $3.68.

Generex Biotechnology Corporation ( OTCMKTS:GNBT ) recently reported that two abstracts in respect of results of the on-going Phase II study of a novel cancer vaccine designed to prevent relapse in patients who have had breast cancer will be presented at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to be held in Chicago from May 30 to June 3, 2014.

Generex Biotechnology Corporation ( OTCMKTS:GNBT ) traded with volume of 4.06 million shares and the average volume of the stock remained 2.69 shares. The stock grew 9.22% and finished the trading at $0.0320.
